Alx Oncology Holdings (ALXO) Other Working Capital Changes (2019 - 2026)

Alx Oncology Holdings has disclosed Other Working Capital Changes across 8 years of filings, most recently posting -$418000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$418000.0, up 77.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 125.53% YoY), and the FY2025 annual result was $686000.0, up 133.12% from the prior year.
• Other Working Capital Changes came in at -$418000.0 for Q1 2026 at Alx Oncology Holdings, down from $2.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $4.5 million in Q1 2024 to a low of -$8.2 million in Q3 2024.
• The 5-year median for Other Working Capital Changes is $99000.0 (2024), against an average of -$301941.2.
• Across the five-year window, Other Working Capital Changes plunged 471.29% in 2023 and surged 2114.14% in 2025, its largest moves.
• Alx Oncology Holdings' Other Working Capital Changes stood at -$3.6 million in 2022, then plunged by 85.6% to -$6.7 million in 2023, then jumped by 101.49% to $99000.0 in 2024, then soared by 2114.14% to $2.2 million in 2025, then tumbled by 119.07% to -$418000.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$418000.0 (Q1 2026), $2.2 million (Q4 2025), and -$854000.0 (Q3 2025), per Business Quant data.